deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT01287780

Local Gentamicin Application to Reduce Postoperative Infection Rate

Local Gentamicin Application to Reduce Postoperative Infection Rate in Hemiarthroplasty After Fracture of the Proximal Femur: a Randomized Controlled Trial

Sponsor: Oslo University Hospital

Conditions Surgical Wound Infection
Interventions Collagen-gentamicin sponge
Updated 5 times since 2017 Last updated: Aug 15, 2013 Started: Jan 31, 2011 Primary completion: Jul 31, 2013 Completion: Aug 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Surgical Wound Infection and is currently completed. Oslo University Hospital leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oslo University Hospital
Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations